F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Everolimus

Page 1 of 1 ( 25 items )
<<
1
>>

1	Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature 10/21/2022 2:24:59 AM \| Browse: 350 \| Download: 825
2	Current aspects of renal dysfunction after liver transplantation 1/21/2022 8:16:14 AM \| Browse: 490 \| Download: 1082
3	Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report 5/20/2021 3:14:20 PM \| Browse: 517 \| Download: 1233
4	Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario 12/17/2020 9:42:32 AM \| Browse: 666 \| Download: 1449
5	Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 12/21/2018 1:32:15 AM \| Browse: 897 \| Download: 1102
6	Introduction of everolimus in kidney transplant recipients at a late posttransplant stage 9/7/2018 6:15:25 AM \| Browse: 911 \| Download: 1517
7	Use of everolimus in liver transplantation 8/18/2017 1:45:25 AM \| Browse: 1075 \| Download: 1276
8	Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation 6/20/2017 12:12:53 PM \| Browse: 942 \| Download: 1610
9	Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate 4/7/2017 8:24:12 AM \| Browse: 1070 \| Download: 1366
10	Growth hormone abolishes the negative effects of everolimus on intestinal wound healing 4/29/2016 4:50:00 PM \| Browse: 1405 \| Download: 2335
11	Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale? 4/7/2016 11:01:00 AM \| Browse: 1115 \| Download: 1783
12	Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 3/30/2016 2:15:00 PM \| Browse: 1057 \| Download: 1637
13	Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis 3/21/2016 8:54:00 AM \| Browse: 1060 \| Download: 1486
14	Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation 3/18/2016 2:28:00 PM \| Browse: 1217 \| Download: 1860
15	Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients 12/23/2015 8:26:00 AM \| Browse: 1153 \| Download: 2042
16	Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful 12/23/2015 8:26:00 AM \| Browse: 1021 \| Download: 2340
17	Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center 12/23/2015 8:26:00 AM \| Browse: 1378 \| Download: 2855
18	Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic 12/9/2015 6:37:00 PM \| Browse: 1076 \| Download: 1663
19	Mammalian target of rapamycin inhibition in hepatocellular carcinoma 12/2/2015 12:16:00 PM \| Browse: 1199 \| Download: 1379
20	Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges 4/19/2015 5:46:00 PM \| Browse: 1226 \| Download: 1748
21	Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions 12/11/2014 2:06:00 PM \| Browse: 1146 \| Download: 1390
22	Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors 11/17/2014 3:13:00 PM \| Browse: 1039 \| Download: 1381
23	Hepatitis B reactivation related to everolimus 9/10/2014 3:18:00 PM \| Browse: 1031 \| Download: 611
24	Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients 8/25/2014 9:54:00 AM \| Browse: 972 \| Download: 1214
25	Multiple indications for everolimus after liver transplantation in current clinical practice 8/25/2014 9:54:00 AM \| Browse: 1024 \| Download: 1021

Page 1 of 1 ( 25 items )
<<
1
>>

1	Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature 10/21/2022 2:24:59 AM \| Browse: 350 \| Download: 825
2	Current aspects of renal dysfunction after liver transplantation 1/21/2022 8:16:14 AM \| Browse: 490 \| Download: 1082
3	Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report 5/20/2021 3:14:20 PM \| Browse: 517 \| Download: 1233
4	Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario 12/17/2020 9:42:32 AM \| Browse: 666 \| Download: 1449
5	Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 12/21/2018 1:32:15 AM \| Browse: 897 \| Download: 1102
6	Introduction of everolimus in kidney transplant recipients at a late posttransplant stage 9/7/2018 6:15:25 AM \| Browse: 911 \| Download: 1517
7	Use of everolimus in liver transplantation 8/18/2017 1:45:25 AM \| Browse: 1075 \| Download: 1276
8	Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation 6/20/2017 12:12:53 PM \| Browse: 942 \| Download: 1610
9	Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate 4/7/2017 8:24:12 AM \| Browse: 1070 \| Download: 1366
10	Growth hormone abolishes the negative effects of everolimus on intestinal wound healing 4/29/2016 4:50:00 PM \| Browse: 1405 \| Download: 2335
11	Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale? 4/7/2016 11:01:00 AM \| Browse: 1115 \| Download: 1783
12	Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 3/30/2016 2:15:00 PM \| Browse: 1057 \| Download: 1637
13	Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis 3/21/2016 8:54:00 AM \| Browse: 1060 \| Download: 1486
14	Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation 3/18/2016 2:28:00 PM \| Browse: 1217 \| Download: 1860
15	Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients 12/23/2015 8:26:00 AM \| Browse: 1153 \| Download: 2042
16	Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful 12/23/2015 8:26:00 AM \| Browse: 1021 \| Download: 2340
17	Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center 12/23/2015 8:26:00 AM \| Browse: 1378 \| Download: 2855
18	Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic 12/9/2015 6:37:00 PM \| Browse: 1076 \| Download: 1663
19	Mammalian target of rapamycin inhibition in hepatocellular carcinoma 12/2/2015 12:16:00 PM \| Browse: 1199 \| Download: 1379
20	Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges 4/19/2015 5:46:00 PM \| Browse: 1226 \| Download: 1748
21	Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions 12/11/2014 2:06:00 PM \| Browse: 1146 \| Download: 1390
22	Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors 11/17/2014 3:13:00 PM \| Browse: 1039 \| Download: 1381
23	Hepatitis B reactivation related to everolimus 9/10/2014 3:18:00 PM \| Browse: 1031 \| Download: 611
24	Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients 8/25/2014 9:54:00 AM \| Browse: 972 \| Download: 1214
25	Multiple indications for everolimus after liver transplantation in current clinical practice 8/25/2014 9:54:00 AM \| Browse: 1024 \| Download: 1021